{"title": null, "author": null, "url": null, "hostname": null, "description": null, "sitename": null, "date": "2004-01-01", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Perspectivas para nuevas vacunas antituberculosas en la era posgen\u00f3mica\n[Biom\u00e9dica (Bogot\u00e1)](http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=Biom\u00e9dica (Bogot\u00e1)); 24(supl.1): 228-238, jun. 2004. ilus\nArtigo em Espanhol | LILACS | ID: lil-635466\nBiblioteca respons\u00e1vel:\n[CO332](http://centros.bvsalud.org/?search=CO332&prefix=search&lang=pt)\nRESUMENA\n[pesar]de que la [vacunaci\u00f3n]con [Mycobacterium bovis] [BCG]es el [procedimiento]m\u00e1s utilizado a nivel mundial para prevenir la [tuberculosis], su eficicacia es muy cuestionable, lo cual ha motivado la b\u00fasqueda de nuevas opciones inmunoprofil\u00e1cticas. El [conocimiento]generado con el secuenciamiento completo de una cepa de Mycobacterium tuberculosis H37Rv y la aplicaci\u00f3n de nuevas [tecnolog\u00edas]inmunol\u00f3gicas, bioqu\u00edmicas y gen\u00e9ticas han permitido realizar una [disecci\u00f3n]fina del [transcriptoma]y el [proteoma]de M. tuberculosis, lo cual ha generado una gran cantidad de [conocimiento]sobre la [biolog\u00eda]de este microorganismo. Dado que alrededor de una tercera parte de la [poblaci\u00f3n mundial]puede estar infectada con M. tuberculosis y que \u00e9ste s\u00f3lo se detecta cuando se inicia la [enfermedad], la mayor parte de los esfuerzos se han dedicado al dise\u00f1o de [vacunas]posinfecci\u00f3n que induzcan un aumento selectivo de la [inmunidad celular]espec\u00edfica del hospedero a largo plazo, no generen reacciones adversas y sean de [bajo costo]. Dentro de las nuevas [estrategias]que est\u00e1n siendo utilizadas para el [desarrollo de vacunas], se destaca la utilizaci\u00f3n de mezclas de [prote\u00ednas]con una alta inmunogenicidad, cepas de M. bovis [BCG]recombinantes y de M. tuberculosis gen\u00e9ticamente atenuadas o modificadas para inducir una mayor [respuesta inmune], y las [vacunas]de AND desnudo. Los candidatos con m\u00e1s potencial incluyen las [vacunas]de subunidades micobacterianas, las cuales expresan mol\u00e9culas ampliamente reconocidas por el [sistema inmune]y cuyo reconocimiento resulta en el incremento de la respuesta Th1 y aqu\u00e9llas que utilizan vectores virales dise\u00f1ados para expresar mol\u00e9culas micobacterianas antig\u00e9nicas. Aunque los [modelos animales]son de valor limitado, puesto que la [patolog\u00eda]observada en ellos s\u00f3lo reproduce parcialmente la observada en [humanos], los resultados obtenidos con estas [vacunas]son muy prometedores y algunas est\u00e1n siendo actualmente evaluadas en ensayos cl\u00ednicos de fase I.\nABSTRACTPerspectives for new anti-tuberculous\n[vaccines]in the post-genomic era [Vaccination]with attenuated [Mycobacterium bovis] [BCG]has been used as the routine [procedure]to immunize against [tuberculosis]. Since the [efficacy]of [BCG] [vaccination]is very controversial, the search for new immunoprophylatic tools against [tuberculosis]is an area of intense interest. [Knowledge]of the complete sequence of [Mycobacterium tuberculosis](Mtb) H37Rv [genome]and the application of new immunological, biochemical and genetic [technologies]has led to a detailed [understanding]of the [transcriptome]and [proteome]of this bacterium. Approximately one-third of the [human] [population]is infected with Mtb; however, the [bacillus]is only detected once the symptoms appear and therefore most of the recent efforts have been devoted to the development of a post- [infection] [vaccine]. In theory, this [vaccine](1) [will]give rise to an increase in the long-lasting specific [immunity]against Mtb, (2) [will]not have significant [adverse effects], and (3) [will]be affordable for the people in [third world countries]. The main [strategies]that have been developed include the [subunit vaccines], either as a mixture of relevant immunogenic [proteins]or [DNA]constructs, recombinant [strains]of [Mycobacterium bovis] [BCG]and Mtb, designed to secrete immunogenic [proteins]or with attenuated [virulence], respectively, and [DNA]-based [vaccines]. The [subunit vaccines]are delivered either as mixtures of immunogenic [proteins]and adjuvants, or as naked [DNA]or by viral vectors in order to induce a potent Th1 response. Most of these [vaccines]have been tested in several kinds of [animal models], but they do not fully reproduce the [human] [pathology]. However, the results obtained so far are very encouraging and have led to the development of phase I trials in [humans].\nTexto completo: Dispon\u00edvel Cole\u00e7\u00f5es: Bases de dados internacionais Contexto em Sa\u00fade: ODS3 - Sa\u00fade e Bem-Estar / Doen\u00e7as Negligenciadas Problema de sa\u00fade: Meta 3.3: Acabar com as doen\u00e7as tropicais negligenciadas e combater as doen\u00e7as transmiss\u00edveis / Doen\u00e7as Negligenciadas / Tuberculose / Zoonoses Base de dados: LILACS Assunto principal: Tuberculose / Vacinas contra a Tuberculose Limite: Animais / Humanos Idioma: Espanhol Revista: Biom\u00e9dica (Bogot\u00e1) Assunto da revista: Medicina Ano de publica\u00e7\u00e3o: 2004 Tipo de documento: Artigo Pa\u00eds de afilia\u00e7\u00e3o: Col\u00f4mbia", "language": null, "image": null, "pagetype": null, "links": ["#main_container", "#pesquisa", "#footer", "#", "#", "#", "#", "https://politicas.bireme.org/accesibilidad/pt/", "http://bvsalud.org/", "javascript:change_language('pt')", "javascript:change_language('es')", "javascript:change_language('en')", "javascript:change_language('fr')", "https://pesquisa.bvsalud.org/portal/decs-locator/?lang=pt", "https://pesquisa.bvsalud.org/portal/advanced/?lang=pt", "http://bvsalud.org/evideasy/pt", "#", "http://bvsalud.org/", "https://pesquisa.bvsalud.org/portal/?lang=pt", "https://pesquisa.bvsalud.org/portal/?lang=pt&q=au:\"Garc\u00eda, Luis F\"", "https://pesquisa.bvsalud.org/portal/?lang=pt&q=au:\"Barrera, Luis F\"", "http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=Biom\u00e9dica (Bogot\u00e1)", "http://centros.bvsalud.org/?search=CO332&prefix=search&lang=pt", "https://www.facebook.com/sharer.php?u=https://pesquisa.bvsalud.org/portal/resource/pt/lil-635466", "https://twitter.com/intent/tweet?text=Perspectivas para nuevas vacunas antituberculosas en la era posgen\u00f3mica https://pesquisa.bvsalud.org/portal/resource/pt/lil-635466", "https://www.linkedin.com/shareArticle?mini=true&url=https://pesquisa.bvsalud.org/portal/resource/pt/lil-635466&title=Perspectivas para nuevas vacunas antituberculosas en la era posgen\u00f3mica - Portal Regional da BVS", "https://api.whatsapp.com/send?text=Perspectivas para nuevas vacunas antituberculosas en la era posgen\u00f3mica - Portal Regional da BVS - https://pesquisa.bvsalud.org/portal/resource/pt/lil-635466", "#mark_ab_es", "#mark_ab_en", null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, "https://pesquisa.bvsalud.org/portal/?lang=pt&q=mh:\"Animais\"", "https://pesquisa.bvsalud.org/portal/?lang=pt&q=mh:\"Humanos\"", "https://pesquisa.bvsalud.org/portal/?lang=pt&q=mh:\"Vacinas contra a Tuberculose\"", "https://pesquisa.bvsalud.org/portal/?lang=pt&q=mh:\"Tuberculose/preven\u00e7\u00e3o %26 controle\"", "https://pesquisa.bvsalud.org/portal/?lang=pt&q=mh:\"Genoma Bacteriano\"", "https://pesquisa.bvsalud.org/portal/?lang=pt&q=mh:\"Mycobacterium tuberculosis/gen\u00e9tica\"", "https://pesquisa.bvsalud.org/portal/?lang=pt&q=mh:\"Tuberculose/microbiologia\"", "https://pesquisa.bvsalud.org/portal/?lang=pt&q=kw:\"Mycobacterium tuberculosis\"", "https://pesquisa.bvsalud.org/portal/?lang=pt&q=kw:\"Mycobacterium tuberculosis\"", "https://pesquisa.bvsalud.org/portal/?lang=pt&q=kw:\"Tuberculosis\"", "https://pesquisa.bvsalud.org/portal/?lang=pt&q=kw:\"Tuberculosis\"", "https://pesquisa.bvsalud.org/portal/?lang=pt&q=kw:\"Vaccines\"", "https://pesquisa.bvsalud.org/portal/?lang=pt&q=kw:\"Vacunas\"", "http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-41572004000500026", "javascript:;", "javascript:window.print()", "javascript:export_xml_record('lil-635466');", "https://www.google.com/search?q=\"Perspectivas para nuevas vacunas antituberculosas en la era posgen\u00f3mica\"", "http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-41572004000500026", "javascript:;", "javascript:window.print()", "javascript:export_xml_record('lil-635466');", "https://www.google.com/search?q=\"Perspectivas para nuevas vacunas antituberculosas en la era posgen\u00f3mica\"", "https://bvsalud.org/contate-nos/", "http://politicas.bireme.org/terminos/pt/", "http://politicas.bireme.org/privacidad/pt/", "javascript:change_output('rss');", "javascript:;", "javascript:print_page();", "javascript:print_page(true);"]}